YATHARTH.NS
YATHARTH.NS
INE0JO301016
YATHARTH HOSP & TRA C S L
Loading chart...

Company Profile

Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surgery and liver transplant, robotic surgery, kidney transplant, IVF and fertility, emergency medicine, ophthalmology, dentistry, psychology and psychiatry, physiotherapy and rehabilitation, anesthesiology, radiology, pathology and laboratory medicine, nutrition and health, interventional spine and pain medicine, and transfusion medicine and cellular therapy. In addition, the company sells medicines, as well as provide cafeteria services. The company was incorporated in 2008 and is based in Noida, India.

Related stocks

PARKHOSPS.NS
PARKHOSPS.NS • India
PARK MEDI WORLD LIMITED
270.8 INR
1.21B USD
NEPHROPLUS.NS
NEPHROPLUS.NS • India
NEPHROCARE HEALTH SERV L
616.4 INR
640.47M USD
REG.AX
REG.AX • Australia
REG HEALTH FPO [REG]
4.39 AUD
927.83M USD 1Y -33.2%
KOVAI.BO
KOVAI.BO • India
KOVAI MEDICAL CENTER & HOSPITA
5,879.7 INR
664.78M USD 1Y -8.6%
JLHL.NS
JLHL.NS • India
JUPITER LIFE LINE HOSP L
255.7 INR
866.15M USD 1Y -19.7%
JLHL.NS
JLHL.NS • India
JUPITER LIFE LINE HOSP L
255.7 INR
866.15M USD 1Y -19.7%
RAINBOW.NS
RAINBOW.NS • India
RAINBOW CHILDRENS MED LTD
1,250.2 INR
1.31B USD 1Y -6.4%
HCG.NS
HCG.NS • India
HEALTHCARE GLOB. ENT. LTD
589.2 INR
908.96M USD 1Y -13.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
39.4% p.a.
Max Drawdown (3Y)
-47.7%
Sharpe Ratio (3Y)
0.84
Beta Factor
1.00
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 54.4 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende